Diana Lake

Diana Lake

UNVERIFIED PROFILE

Are you Diana Lake?   Register this Author

Register author
Diana Lake

Diana Lake

Publications by authors named "Diana Lake"

Are you Diana Lake?   Register this Author

30Publications

779Reads

36Profile Views

Adjuvant chemotherapy for node negative, high Recurrence Score breast cancer: in defense of de-escalation.

NPJ Breast Cancer 2019 12;5:24. Epub 2019 Aug 12.

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0119-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690957PMC
August 2019

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

J Clin Oncol 2016 08 2;34(22):2602-9. Epub 2016 May 2.

Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012690PMC
August 2016

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).

J Clin Oncol 2014 Dec 27;32(35):3959-66. Epub 2014 Oct 27.

Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.7941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251959PMC
December 2014

Cystoid macular edema secondary to nab-paclitaxel therapy.

J Clin Oncol 2010 Nov 30;28(33):e684-7. Epub 2010 Aug 30.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.3750DOI Listing
November 2010

High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer.

Anticancer Res 2008 Sep-Oct;28(5B):3139-42

Division of Oncology and Hematology, New York Medical College and Zalmen A. Arlin Cancer Institute, Westchester Medical Center, Valhalla, NY, USA.

View Article

Download full-text PDF

Source
January 2009

High-dose chemotherapy in breast cancer.

Drugs 2004 ;64(17):1851-60

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200464170-00001DOI Listing
December 2004

Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332.

Am J Clin Oncol 2004 Feb;27(1):19-23

Mayo Clinic Jacksonville, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000045850.98788.edDOI Listing
February 2004

Aromatase inhibitors in breast cancer: an update.

Cancer Control 2002 Nov-Dec;9(6):490-8

Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/107327480200900606
Publisher Site
http://dx.doi.org/10.1177/107327480200900606DOI Listing
March 2003